First Time Loading...

Maravai LifeSciences Holdings Inc
NASDAQ:MRVI

Watchlist Manager
Maravai LifeSciences Holdings Inc Logo
Maravai LifeSciences Holdings Inc
NASDAQ:MRVI
Watchlist
Price: 8.8 USD 4.51% Market Closed
Updated: May 3, 2024
Section:
 

Wall Street
Price Targets

MRVI Price Targets Summary
Maravai LifeSciences Holdings Inc

Wall Street analysts forecast MRVI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MRVI is 10.07 USD with a low forecast of 6.57 USD and a high forecast of 15.75 USD.

MRVI Lowest Forecast
Wall Street Target
6.57 USD
25% Downside
MRVI Average Forecast
Wall Street Target
10.07 USD
14% Upside
MRVI Highest Forecast
Wall Street Target
15.75 USD
79% Upside
Lowest
Price Target
6.57 USD
25% Downside
Average
Price Target
10.07 USD
14% Upside
Highest
Price Target
15.75 USD
79% Upside
Maravai LifeSciences Holdings Inc Competitors:
Price Targets
IQV
IQVIA Holdings Inc
27% Upside
S
237690
ST Pharm Co Ltd
24% Upside
300404
Boji Medical Technology Co Ltd
553% Upside
NEO
Neogenomics Inc
46% Upside
IQV
IQVIA Holdings Inc
27% Upside
S
237690
ST Pharm Co Ltd
24% Upside
300404
Boji Medical Technology Co Ltd
553% Upside
NEO
Neogenomics Inc
46% Upside
DXRX
Diaceutics PLC
71% Upside
CHEMM
Chemometec A/S
63% Upside
SFZN
Siegfried Holding AG
16% Upside
S
SLV
Selvita SA
9% Upside

Revenue
Forecast

Revenue Estimate
Maravai LifeSciences Holdings Inc

For the last 4 years the compound annual growth rate for Maravai LifeSciences Holdings Inc's revenue is 19%. The projected CAGR for the next 3 years is 7%.

19%
Past Growth
7%
Estimated Growth
Estimates Accuracy
1%
Average Beat
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Maravai LifeSciences Holdings Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-9%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Maravai LifeSciences Holdings Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-52%
Average Miss
What are analyst estimates?

See Also

Summary
MRVI intrinsic value, competitors valuation, and company profile.
DCF Valuation
MRVI stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MRVI stock valuation using valuation multiples.
Wall Street Estimates
MRVI price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MRVI stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MRVI's stock price target?
Price Target
10.07 USD

According to Wall Street analysts, the average 1-year price target for MRVI is 10.07 USD with a low forecast of 6.57 USD and a high forecast of 15.75 USD.

What is Maravai LifeSciences Holdings Inc's Revenue forecast?
Projected CAGR
7%

For the last 4 years the compound annual growth rate for Maravai LifeSciences Holdings Inc's revenue is 19%. The projected CAGR for the next 3 years is 7%.

ALPHA SPREAD
Join more than 133,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.